Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Pfizer Inc(PFE US)

$30.03-0.391.28%Ext:$29.76-0.270.89%(Market Closed · 00:00:05 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
PFE US​

SEC Filings

Financials(131)

Expand
  • 10-QQ2ended 28 Jun 20264 Aug
  • 10-QQ1ended 29 Mar 20265 May
  • 10-KFY 2025ended 31 Dec 202526 Feb
  • 10-QQ3ended 28 Sept 20254 Nov 2025
  • 10-QQ2ended 29 Jun 20255 Aug 2025
  • 10-QQ1ended 30 Mar 20255 May 2025
  • 10-KFY 2024ended 31 Dec 202427 Feb 2025
  • 10-QQ3ended 29 Sept 20244 Nov 2024
  • 10-QQ2ended 30 Jun 20245 Aug 2024
  • 10-QQ1ended 31 Mar 20248 May 2024
  • 10-KFY 2023ended 31 Dec 202322 Feb 2024
  • 10-QQ3ended 1 Oct 20238 Nov 2023
  • 10-QQ2ended 2 Jul 20239 Aug 2023
  • 10-QQ1ended 2 Apr 202310 May 2023
  • 10-QQ3ended 2 Oct 20229 Nov 2022

Events(356)

Expand
  • 8-KResults of Operations and Financial Condition4 Aug
  • 8-KRegulation FD Disclosure18 Jun
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers18 Jun
  • 8-KResults of Operations and Financial Condition5 May
  • 8-KSubmission of Matters to a Vote of Security Holders27 Apr
  • 8-KResults of Operations and Financial Condition3 Feb
  • 8-KRegulation FD Disclosure16 Dec 2025
  • 8-KOther Events21 Nov 2025
  • 8-KOther Events13 Nov 2025
  • 8-KResults of Operations and Financial Condition4 Nov 2025
  • 8-KResults of Operations and Financial Condition5 Aug 2025
  • 8-KOther Events19 May 2025
  • 8-KResults of Operations and Financial Condition29 Apr 2025
  • 8-KSubmission of Matters to Shareholder Vote28 Apr 2025
  • 8-KResults of Operations and Financial Condition4 Feb 2025

Insider Ownership(5.2K)

Expand
  • 4BOURLA ALBERT16 Oct
  • 4BOURLA ALBERT14 Oct
  • 4BOURLA ALBERT1 Oct
  • 4Buckley Mortimer J29 Sep
  • 4Echevarria Joseph29 Sep
  • 4NARAYEN SHANTANU29 Sep
  • 4Quincey James29 Sep
  • 4Taraporevala Cyrus29 Sep
  • 4SMITH JAMES C29 Sep
  • 4BOURLA ALBERT16 Sep
  • 4BOURLA ALBERT1 Sep
  • 3Guegan Cecile28 Aug
  • 4BOURLA ALBERT17 Aug
  • 4BOURLA ALBERT12 Aug
  • 4DAMICO JENNIFER B.6 Aug

Beneficial Ownership(200)

Expand
  • SC 13GTRex Bio, Inc.16 Oct
  • SC 13G/AOric Pharmaceuticals, Inc.12 May
  • SC 13GPFIZER INC1 May
  • SC 13G/APFIZER INC27 Mar
  • SC 13D/AAllogene Therapeutics, Inc.13 Feb
  • SC 13G/AQ32 Bio Inc.13 Feb
  • SC 13G/ANextCure, Inc.13 Feb
  • SC 13D/AHaleon plc24 Mar 2025
  • SC 13D/AHaleon plc20 Mar 2025
  • SC 13D/AHaleon plc27 Feb 2025
  • SC 13G/ACardiff Oncology, Inc.12 Feb 2025
  • SC 13G/AZura Bio Ltd12 Feb 2025
  • SC 13D/AHaleon plc21 Jan 2025
  • SC 13D/AHaleon plc16 Jan 2025
  • SC 13D/AHaleon plc3 Oct 2024

Other Ownership(99)

Expand
  • 13F-HRQuarterly report (institutional investment manager holdings)13 Aug
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)16 Jun
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)16 Jun
  • 13F-HRQuarterly report (institutional investment manager holdings)12 May
  • 13F-HRQuarterly report (institutional investment manager holdings)12 Feb
  • 13F-HRQuarterly report (institutional investment manager holdings)13 Nov 2025
  • 13F-HRQuarterly report (institutional investment manager holdings)11 Aug 2025
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)16 Jun 2025
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)16 Jun 2025
  • 144Dolsten Mikael23 May 2025
  • 13F-HRQuarterly report (institutional investment manager holdings)13 May 2025
  • 144Dolsten Mikael5 May 2025
  • 13F-HRQuarterly report (institutional investment manager holdings)14 Feb 2025
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)11 Jun 2024
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)11 Jun 2024

Proxies(123)

Expand
  • N-PXAnnual report of proxy voting record31 Aug
  • ARSAnnual report to security holders12 Mar
  • DEFA14ADefinitive additional materials12 Mar
  • DEF 14ADefinitive proxy statement12 Mar
  • DEFA14ADefinitive additional materials11 Apr 2025
  • DEFA14ADefinitive additional materials10 Apr 2025
  • DEFA14ADefinitive additional materials10 Apr 2025
  • DEFA14ADefinitive additional materials10 Apr 2025
  • DEFA14ADefinitive additional materials7 Apr 2025
  • PX14A6GNotice of exempt solicitation25 Mar 2025
  • DEFA14ADefinitive additional materials13 Mar 2025
  • ARSAnnual report to security holders13 Mar 2025
  • DEF 14ADefinitive proxy statement13 Mar 2025
  • PX14A6GNotice of exempt solicitation16 Apr 2024
  • DEFA14ADefinitive additional materials11 Apr 2024

Registrations(333)

Expand
  • S-8Registration statement (employee benefit plan)5 May
  • 424B5Prospectus filing (Rule 424(b)(5))20 Nov 2025
  • FWPFree writing prospectus18 Nov 2025
  • 424B3Prospectus filing (Rule 424(b)(3))18 Nov 2025
  • 8-A12BRegistration of securities (Section 12(b))19 May 2025
  • 424B5Prospectus filing (Rule 424(b)(5))15 May 2025
  • 424B3Prospectus filing (Rule 424(b)(3))13 May 2025
  • POSASRPost-effective amendment (automatic shelf)13 May 2025
  • S-8Registration statement (employee benefit plan)9 May 2024
  • S-8Registration statement (employee benefit plan)23 Feb 2024
  • S-3ASRFORM S-323 Feb 2024
  • 424B5Prospectus filing (Rule 424(b)(5))18 May 2023
  • FWPFree writing prospectus17 May 2023
  • 424B3Prospectus filing (Rule 424(b)(3))15 May 2023
  • POSASRPost-effective amendment (automatic shelf)15 May 2023

Filing Review Correspondence(10)

Expand
  • CORRESPFiling review correspondence22 Aug 2024
  • CORRESPFiling review correspondence12 Apr 2022
  • CORRESPFiling review correspondence23 Dec 2021
  • CORRESPFiling review correspondence19 May 2016
  • CORRESPFiling review correspondence13 Apr 2016
  • CORRESPFiling review correspondence23 Sep 2015
  • CORRESPFiling review correspondence21 Sep 2015
  • CORRESPFiling review correspondence16 Nov 2010
  • CORRESPFiling review correspondence5 May 2009
  • UPLOADFiling review upload22 Apr 2009

SEC Orders And Notices(3)

Expand
  • CT ORDERConfidential treatment order15 Mar 2019
  • EFFECTNotice of effectiveness25 Sep 2015
  • EFFECTNotice of effectiveness17 Jun 2009

Tender Offers And Going Private(71)

Expand
  • SC TO-I/ATender offer statement (issuer, amendment)13 Sep 2024
  • SC TO-I/ATender offer statement (issuer, amendment)22 Aug 2024
  • SC TO-ITender offer statement (issuer)12 Aug 2024
  • SC TO-CTender offer statement (communication)1 Aug 2024
  • SC TO-CTender offer statement (communication)30 Jul 2024
  • SC TO-CTender offer statement (communication)26 Jul 2024
  • SC TO-T/AAMENDMENT NO. 8 TO SCHEDULE TO30 Jul 2019
  • SC TO-T/AAMENDMENT NO.7 TO SCHEDULE TO29 Jul 2019
  • SC TO-T/AAMENDMENT NO. 6 TO SCHEDULE TO25 Jul 2019
  • SC TO-T/AAMENDMENT NO. 5 TO SCHEDULE TO17 Jul 2019
  • SC TO-T/AAMENDMENT NO. 4 TO SCHEDULE TO12 Jul 2019
  • SC TO-T/AAMENDMENT NO. 3 TO SCHEDULE TO11 Jul 2019
  • SC TO-T/ATender offer statement (third-party, amendment)8 Jul 2019
  • SC TO-T/AAMENDMENT NO. 1 TO SCHEDULE TO3 Jul 2019
  • SC TO-TTender offer statement (third-party)28 Jun 2019

Other(100)

Expand
  • SDSD30 May 2025
  • CERTCERT20 May 2025
  • SDSD31 May 2024
  • SDSD31 May 2018
  • SDSD31 May 2017
  • CERTNYSAUTO-GENERATED PAPER DOCUMENT7 Mar 2017
  • NO ACTAUTO-GENERATED PAPER DOCUMENT10 Feb 2017
  • NO ACTAUTO-GENERATED PAPER DOCUMENT31 Jan 2017
  • NO ACTAUTO-GENERATED PAPER DOCUMENT26 Jan 2017
  • NO ACTAUTO-GENERATED PAPER DOCUMENT10 Jan 2017
  • NO ACTAUTO-GENERATED PAPER DOCUMENT27 Dec 2016
  • SDSD31 May 2016
  • NO ACTAUTO-GENERATED PAPER DOCUMENT1 Mar 2016
  • NO ACTAUTO-GENERATED PAPER DOCUMENT29 Feb 2016
  • NO ACTAUTO-GENERATED PAPER DOCUMENT29 Jan 2016